Statin Related Myopathy and Vitamin D

Autores
Mansur, José Luis
Año de publicación
2018
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Statins are usually safe and well tolerated drugs, very effective for cardiovascular prevention. The presence of myopathy, rare, but with different incidence in different reports, is one of the causes of abandonment of its use. It has begun to report association between decreased vitamin D levels and increased risk of myopathy, on the one hand, and reports where patients who stop statins consumption due to myalgia, with vitamin D deficiency, can tolerate these drugs once the vitamin is supplemented to values desirable Another factor clearly related to myopathy is the presence of polymorphisms in enzyme genes that metabolize or transport statins. As many patients with vitamin D deficiency do not have pain or are completely asymptomatic (with or without statins), we may consider it as a risk factor for developing myopathy due to statins (such as the simultaneous administration of drugs that are metabolized by the same cytochrome P450 pathway, or the presence of mentioned polymorphisms). In conclusion, the finding that having Vitamin D deficiency is associated with statin myopathy, or is a risk factor to develop it, opens new perspectives for a huge number of patients who abandon this treatment due to this condition.
Facultad de Ciencias Médicas
Materia
Medicina
Vitamin D
statins
Statin-Related Myopathy
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by-nc-sa/4.0/
Repositorio
SEDICI (UNLP)
Institución
Universidad Nacional de La Plata
OAI Identificador
oai:sedici.unlp.edu.ar:10915/151970

id SEDICI_11aba8efd89c8a53db6ddc544800f77a
oai_identifier_str oai:sedici.unlp.edu.ar:10915/151970
network_acronym_str SEDICI
repository_id_str 1329
network_name_str SEDICI (UNLP)
spelling Statin Related Myopathy and Vitamin DMansur, José LuisMedicinaVitamin DstatinsStatin-Related MyopathyStatins are usually safe and well tolerated drugs, very effective for cardiovascular prevention. The presence of myopathy, rare, but with different incidence in different reports, is one of the causes of abandonment of its use. It has begun to report association between decreased vitamin D levels and increased risk of myopathy, on the one hand, and reports where patients who stop statins consumption due to myalgia, with vitamin D deficiency, can tolerate these drugs once the vitamin is supplemented to values desirable Another factor clearly related to myopathy is the presence of polymorphisms in enzyme genes that metabolize or transport statins. As many patients with vitamin D deficiency do not have pain or are completely asymptomatic (with or without statins), we may consider it as a risk factor for developing myopathy due to statins (such as the simultaneous administration of drugs that are metabolized by the same cytochrome P450 pathway, or the presence of mentioned polymorphisms). In conclusion, the finding that having Vitamin D deficiency is associated with statin myopathy, or is a risk factor to develop it, opens new perspectives for a huge number of patients who abandon this treatment due to this condition.Facultad de Ciencias Médicas2018info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf1-6http://sedici.unlp.edu.ar/handle/10915/151970enginfo:eu-repo/semantics/altIdentifier/url/https://gratisoa.org/journals/index.php/ACEM/article/view/1382info:eu-repo/semantics/altIdentifier/issn/2641-6425info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-sa/4.0/Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-03T11:11:14Zoai:sedici.unlp.edu.ar:10915/151970Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-03 11:11:14.637SEDICI (UNLP) - Universidad Nacional de La Platafalse
dc.title.none.fl_str_mv Statin Related Myopathy and Vitamin D
title Statin Related Myopathy and Vitamin D
spellingShingle Statin Related Myopathy and Vitamin D
Mansur, José Luis
Medicina
Vitamin D
statins
Statin-Related Myopathy
title_short Statin Related Myopathy and Vitamin D
title_full Statin Related Myopathy and Vitamin D
title_fullStr Statin Related Myopathy and Vitamin D
title_full_unstemmed Statin Related Myopathy and Vitamin D
title_sort Statin Related Myopathy and Vitamin D
dc.creator.none.fl_str_mv Mansur, José Luis
author Mansur, José Luis
author_facet Mansur, José Luis
author_role author
dc.subject.none.fl_str_mv Medicina
Vitamin D
statins
Statin-Related Myopathy
topic Medicina
Vitamin D
statins
Statin-Related Myopathy
dc.description.none.fl_txt_mv Statins are usually safe and well tolerated drugs, very effective for cardiovascular prevention. The presence of myopathy, rare, but with different incidence in different reports, is one of the causes of abandonment of its use. It has begun to report association between decreased vitamin D levels and increased risk of myopathy, on the one hand, and reports where patients who stop statins consumption due to myalgia, with vitamin D deficiency, can tolerate these drugs once the vitamin is supplemented to values desirable Another factor clearly related to myopathy is the presence of polymorphisms in enzyme genes that metabolize or transport statins. As many patients with vitamin D deficiency do not have pain or are completely asymptomatic (with or without statins), we may consider it as a risk factor for developing myopathy due to statins (such as the simultaneous administration of drugs that are metabolized by the same cytochrome P450 pathway, or the presence of mentioned polymorphisms). In conclusion, the finding that having Vitamin D deficiency is associated with statin myopathy, or is a risk factor to develop it, opens new perspectives for a huge number of patients who abandon this treatment due to this condition.
Facultad de Ciencias Médicas
description Statins are usually safe and well tolerated drugs, very effective for cardiovascular prevention. The presence of myopathy, rare, but with different incidence in different reports, is one of the causes of abandonment of its use. It has begun to report association between decreased vitamin D levels and increased risk of myopathy, on the one hand, and reports where patients who stop statins consumption due to myalgia, with vitamin D deficiency, can tolerate these drugs once the vitamin is supplemented to values desirable Another factor clearly related to myopathy is the presence of polymorphisms in enzyme genes that metabolize or transport statins. As many patients with vitamin D deficiency do not have pain or are completely asymptomatic (with or without statins), we may consider it as a risk factor for developing myopathy due to statins (such as the simultaneous administration of drugs that are metabolized by the same cytochrome P450 pathway, or the presence of mentioned polymorphisms). In conclusion, the finding that having Vitamin D deficiency is associated with statin myopathy, or is a risk factor to develop it, opens new perspectives for a huge number of patients who abandon this treatment due to this condition.
publishDate 2018
dc.date.none.fl_str_mv 2018
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Articulo
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://sedici.unlp.edu.ar/handle/10915/151970
url http://sedici.unlp.edu.ar/handle/10915/151970
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://gratisoa.org/journals/index.php/ACEM/article/view/1382
info:eu-repo/semantics/altIdentifier/issn/2641-6425
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.format.none.fl_str_mv application/pdf
1-6
dc.source.none.fl_str_mv reponame:SEDICI (UNLP)
instname:Universidad Nacional de La Plata
instacron:UNLP
reponame_str SEDICI (UNLP)
collection SEDICI (UNLP)
instname_str Universidad Nacional de La Plata
instacron_str UNLP
institution UNLP
repository.name.fl_str_mv SEDICI (UNLP) - Universidad Nacional de La Plata
repository.mail.fl_str_mv alira@sedici.unlp.edu.ar
_version_ 1842260616130068480
score 13.13397